| Oprozomib |
ONX0912 |
935888-69-0 |
| NVP-HSP990(HSP990) |
HSP-990 |
934343-74-5 |
| N-[3-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide |
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 |
918505-84-7 |
| XL147 |
XL147 |
956958-53-5 |
| N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide |
N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺 |
726169-73-9 |
| Acetyl Octapeptide-3 |
乙酰八胜肽-1 |
868844-74-0 |
| MGlu2 agonist |
(1R,2S,4R,5R,6R)-2-[[(2S)-2-氨基-1-氧代丙基]氨基]-4-(1H-1,2,4-三唑-5-基硫基)-双环[3.1.0]己烷-2,6-二甲酸铵盐水合物 |
1311385-32-6 |
| 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine |
GSK2606414 |
1337531-36-8 |
| LY2090314 |
LY 2090314 |
603288-22-8 |
| Linagliptin |
利拉利汀 |
668270-12-0 |
| KU57788(NU7441) |
8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 |
503468-95-9 |
| KML-29 |
KML-29 |
1380424-42-9 |
| Ispinesib |
伊斯平斯 |
336113-53-2 |
| Hoechst 33258 |
赫斯特荧光染料 33258 |
23491-45-4 |
| GSK369796 |
GSK369796 |
1010411-21-8 |
| Ganetespib |
GANETESPIB |
888216-25-9 |
| EPZ004777 |
EPZ004777 |
1338466-77-5 |
| 3-(3,4-Difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethylazepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester |
3-(3,4-二氟苯甲酰基)-1,2,3,6-四氢-1,1-二甲基氮杂卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯 |
629664-81-9 |
| CUDC-101 |
7-[[4-(3-乙炔基苯基氨基)-7-甲氧基喹唑啉-6-基]氧基]-N-羟基庚酰胺 |
1012054-59-9 |
| Cetilistat |
新利司他 |
282526-98-1 |
